Listen
HYDROXYZINE RENAUDIN (hydroxyzine) - Premedication
Opinions on drugs -
Posted on
Jul 29 2024
Reason for request
Reassessment
The Committee deems that the clinical benefit of HYDROXYZINE RENAUDIN (hydroxyzine) 100 mg/2 mL solution for injection is insufficient to justify public funding cover in premedication before general anaesthesia in adults in view of the available alternatives.
Clinical Benefit
| Insufficient |
The Committee deems that the clinical benefit of HYDROXYZINE RENAUDIN (hydroxyzine) 100 mg/2 mL solution for injection is insufficient to justify public funding cover in premedication before general anaesthesia in adults in view of the available alternatives. |
Clinical Added Value
| Not applicable |
Documents
English version
Contact Us
Évaluation des médicaments
